Fig. 1.
Study design. In the ESRD group, semaglutide was given 1–24 h after hemodialysis, with no hemodialysis for 48 h post-dose. ESRD end-stage renal disease, Max maximum, SC subcutaneous
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.